303 related articles for article (PubMed ID: 30116448)
1. Appropriate and Inappropriate Implantable Cardioverter Defibrillators Therapies in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Patients.
Al-Ghamdi B; Mallawi Y; Shafquat A; AlRuwaili N; Alhazaymeh A; Al-Manea W; Al-Fayyadh M
Cardiol Res; 2018 Aug; 9(4):204-214. PubMed ID: 30116448
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
Al-Ghamdi B; Shafquat A; Mallawi Y
Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
Europace; 2023 May; 25(5):. PubMed ID: 37213071
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes.
Wang W; Gasperetti A; Sears SF; Tichnell C; Murray B; Tandri H; James CA; Calkins H
JACC Clin Electrophysiol; 2023 Mar; 9(3):394-402. PubMed ID: 36328892
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
Yin K; Ding L; Li Y; Hua W
Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
9. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
11. Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
Molitor N; Hofer D; Çimen T; Gasperetti A; Akdis D; Costa S; Jenni R; Breitenstein A; Wolber T; Winnik S; Fokstuen S; Fu G; Medeiros-Domingo A; Ruschitzka F; Brunckhorst C; Duru F; Saguner AM
Heart; 2023 Jul; 109(15):1146-1152. PubMed ID: 36889907
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
[TBL] [Abstract][Full Text] [Related]
13. Electrical Storm in ICD Recipients with Arrhythmogenic Right Ventricular Cardiomyopathy.
Yin K; Ding L; Hua W; Zhang S
Pacing Clin Electrophysiol; 2017 Jun; 40(6):683-692. PubMed ID: 28261825
[TBL] [Abstract][Full Text] [Related]
14. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.
Link MS; Laidlaw D; Polonsky B; Zareba W; McNitt S; Gear K; Marcus F; Estes NA
J Am Coll Cardiol; 2014 Jul; 64(2):119-25. PubMed ID: 25011714
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
18. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
Piccini JP; Dalal D; Roguin A; Bomma C; Cheng A; Prakasa K; Dong J; Tichnell C; James C; Russell S; Crosson J; Berger RD; Marine JE; Tomaselli G; Calkins H
Heart Rhythm; 2005 Nov; 2(11):1188-94. PubMed ID: 16253908
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).
Romero J; Grushko M; Briceño DF; Natale A; Di Biase L
Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285
[TBL] [Abstract][Full Text] [Related]
20. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
Assis FR; Krishnan A; Zhou X; James CA; Murray B; Tichnell C; Berger R; Calkins H; Tandri H; Mandal K
Heart Rhythm; 2019 Jul; 16(7):1003-1010. PubMed ID: 30677492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
